IN DOC WE TRUST

Serial Number 90572728
Registration 7213768
700

Registration Progress

Application Filed
Mar 11, 2021
Under Examination
Jan 11, 2022
Approved for Publication
Nov 16, 2021
Published for Opposition
Nov 16, 2021
Registered
Nov 7, 2023

Trademark Image

IN DOC WE TRUST

Basic Information

Serial Number
90572728
Registration Number
7213768
Filing Date
March 11, 2021
Registration Date
November 7, 2023
Published for Opposition
November 16, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 7, 2023
Registration
Registered
Classes
003 005 044

Rights Holder

SanJiva PLLC

16
Address
3130 N Harwood St, APT 1202
Dallas, TX 75201

Ownership History

SanJiva PLLC

Original Applicant
16
Dallas, TX

SanJiva PLLC

Owner at Publication
16
Dallas, TX

SanJiva PLLC

Original Registrant
16
Dallas, TX

Legal Representation

Attorney
Gayatry Nair

USPTO Deadlines

Next Deadline
1368 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20231107)
Due Date
November 07, 2029
Grace Period Ends
May 07, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

32 events
Date Code Type Description Documents
Nov 7, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Nov 7, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 23, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 30, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Sep 29, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Sep 25, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 25, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 25, 2023 ALIE A ASSIGNED TO LIE Loading...
May 5, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 1, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 1, 2023 GNRT O NON-FINAL ACTION E-MAILED Loading...
Mar 1, 2023 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Feb 8, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jan 10, 2023 IUAF S USE AMENDMENT FILED Loading...
Feb 8, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jan 10, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jun 17, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 15, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 15, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 15, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 11, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 16, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 16, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 27, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 13, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 13, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Oct 13, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Oct 13, 2021 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Oct 13, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Oct 7, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 10, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 15, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 003
Skincare and cosmetic products, namely, skin moisturizers
First Use Anywhere: Nov 19, 2022
First Use in Commerce: Nov 19, 2022
Class 005
Skincare and cosmetic products, namely, medicated skin serums
First Use Anywhere: Nov 19, 2022
First Use in Commerce: Nov 19, 2022
Class 044
Medical spa services, namely, minimally invasive and non-invasive cosmetic therapies, namely, lip injections, botulinum toxin injections, chemical peels, body contouring treatments, IV therapies, oxygen treatment, dermaplaning, photofacials, Laser facials, medical grade facials, anti-aging therapy, Hangover treatments, Aesthetic therapies, Platelet-rich plasma (PRP) treatment, Hormone therapy; Healthcare services rendered at a medical spa, namely, prescribing medications for use in connection with minimally invasive and non-invasive cosmetic therapies
First Use Anywhere: Sep 9, 2022
First Use in Commerce: Sep 9, 2022

Classification

International Classes
003 005 044